We are live on
!
Find out more
BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM
$369M
1-Year Est. Return
78.25%
This Fund
S&P 500
1 Year Est. Return
+78.25%
AUM
$369M
AUM Growth
+$44.9M
(+14%)
Holding
95
Top Buys
| 1 | +$61.4M | |
| 2 | +$12.1M | |
| 3 | +$9.4M | |
| 4 |
Corvus Pharmaceuticals
CRVS
|
+$8.7M |
| 5 |
EyePoint Inc
EYPT
|
+$7.78M |
Top Sells
| 1 | +$8.95M | |
| 2 | +$6.86M | |
| 3 | +$5.71M | |
| 4 |
Cullinan Oncology
CGEM
|
+$5.67M |
| 5 |
Context Therapeutics
CNTX
|
+$5.47M |
Sector Composition
| 1 | Healthcare | 76.77% |
| 2 | Financials | 13.91% |
| 3 | Consumer Discretionary | 4.82% |
| 4 | Technology | 2.43% |
| 5 | Real Estate | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKTS
1
Aktis Oncology
AKTS
$1.08B
| $56.6M | 15.33% |
+3,161,348
|
|
||
2
Larimar Therapeutics
LRMR
$374M
| $32M | 8.68% |
7,120,007
+296,317
|
|
||
3
enGene Therapeutics
ENGN
$110M
| $30.1M | 8.15% |
4,416,353
+1,055,416
|
|
||
4
Nuveen Churchill Direct Lending
NCDL
$631M
| $27.3M | 7.39% |
2,143,626
|
|
||
|
5
Cullinan Oncology
CGEM
$798M
| $27.1M | 7.36% |
1,909,764
-441,208
|
|
||
6
Blue Owl Capital
OBDC
$5.54B
| $22.6M | 6.13% |
2,045,070
|
|
||
|
MPLT
7
MapLight Therapeutics
MPLT
$1.38B
| $20.5M | 5.54% |
1,005,929
+678,871
|
|
||
8
Compass Therapeutics
CMPX
$362M
| $15.6M | 4.22% |
2,941,525
-525,000
|
|
||
|
9
Context Therapeutics
CNTX
$130M
| $13.3M | 3.61% |
5,089,015
-2,343,891
|
|
||
10
Holley
HLLY
$311M
| $13M | 3.53% |
4,236,888
+90,252
|
|
||
|
11
EyePoint Inc
EYPT
$1.05B
| $11.8M | 3.19% |
912,594
+520,000
|
|
||
|
12
Corvus Pharmaceuticals
CRVS
$975M
| $7.97M | 2.16% |
+545,000
|
|
||
13
Conduent
CNDT
$208M
| $6.45M | 1.75% |
5,036,595
+214,173
|
|
||
14
Ultragenyx Pharmaceutical
RARE
$2.36B
| $6.34M | 1.72% |
302,638
+90,000
|
|
||
15
Aquestive Therapeutics
AQST
$528M
| $5.59M | 1.52% |
1,347,932
+822,932
|
|
||
16
Rhythm Pharmaceuticals
RYTM
$6.01B
| $5.34M | 1.45% |
+61,455
|
|
||
|
CMPS
17
Compass Pathways
CMPS
$1.54B
| $5M | 1.36% |
904,504
+434,590
|
|
||
18
Immix Biopharma
IMMX
$577M
| $4.99M | 1.35% |
547,552
-438,688
|
|
||
|
IMA
19
ImageneBio Inc
IMA
$64.4M
| $4.8M | 1.3% |
959,337
+135,552
|
|
||
20
Civeo
CVEO
$379M
| $4.78M | 1.29% |
180,475
-190,055
|
|
||
|
LENZ
21
LENZ Therapeutics
LENZ
$204M
| $4.64M | 1.26% |
506,722
+356,722
|
|
||
22
Eledon Pharmaceuticals
ELDN
$276M
| $4.37M | 1.19% |
1,419,912
-510,000
|
|
||
23
KalVista Pharmaceuticals
KALV
$1.44B
| $4.33M | 1.17% |
215,000
-145,000
|
|
||
24
Ovid Therapeutics
OVID
$412M
| $4.23M | 1.15% |
+1,904,666
|
|
||
|
PVLA
25
Palvella Therapeutics
PVLA
$1.53B
| $3.9M | 1.06% |
31,259
-9,000
|
|